Keyphrases
Breast Cancer
100%
Diabetes
100%
Insulin Therapy
100%
Women with Diabetes
100%
Insulin
75%
Insulin Analogues
62%
Breast Tumor
50%
Without Diabetes
50%
Tumor
37%
Incidence Rate
37%
Breast Cancer Risk
37%
Breast Cancer Subtypes
37%
Breast Cancer Progression
25%
Type 2 Diabetes Mellitus (T2DM)
25%
Clinical Practice Research Datalink
25%
Phosphoinositide 3-kinase (PI3K)
25%
Breast Cancer in Women
25%
Human Epidermal Growth Factor Receptor 2 (HER2)
12%
Breast Cancer Patients
12%
Signaling Pathway
12%
Gene Expression
12%
High Risk
12%
Protein Expression
12%
Non-associated
12%
Breast Cancer Mortality
12%
Patients with Diabetes
12%
Denmark
12%
United Kingdom
12%
Tumor Tissue
12%
Gene Expression Analysis
12%
Epidemiological Evidence
12%
Poor Prognosis
12%
Tumor Development
12%
Postmenopausal Women
12%
In Vivo Evidence
12%
Insulin-like Growth Factor 1 Receptor (IGF1R)
12%
Non-insulin
12%
Trends in Incidence
12%
Hormone Receptor-positive
12%
Tumor Initiation
12%
Mitogenic Signaling
12%
Human Insulin
12%
In Vitro-in Vivo
12%
Tumor Marker
12%
Primary Invasive Breast Cancer
12%
Insulin-treated
12%
Clinical Pathological Characteristics
12%
Insulin Signaling Pathway
12%
Hospital-based Cohort
12%
Medicine and Dentistry
Breast Cancer
100%
Diabetes
100%
Insulin Treatment
100%
Breast Tumor
35%
Insulin Derivative
35%
Neoplasm
28%
Maturity Onset Diabetes of the Young
14%
Signal Transduction
14%
Mitogen-Activated Protein Kinase
14%
Systematic Review
7%
Gene Expression
7%
In Vitro
7%
Protein Expression
7%
Receptor
7%
Cancer Risk
7%
Tumor Progression
7%
Gene Expression Profiling
7%
Tumor Marker
7%
Cancer Incidence
7%
Patient with Diabetes
7%
Insulin Signaling
7%
Human Insulin
7%
Tumor Initiation
7%
Premenopause
7%
Recombinant Human Insulin
7%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Insulin Analog
38%
Breast Tumor
38%
Neoplasm
30%
Non Insulin Dependent Diabetes Mellitus
15%
Tumor Growth
7%
Receptor
7%
Cancer Incidence
7%
Human Insulin
7%
Tumor Marker
7%
Recombinant Human Insulin
7%